Delivery Order SPE2DR25D1100-SPE2DR26FCV7A
- Not listed
- The Defense Logistics Agency awarded a $2,499.65 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price delivery order with completion scheduled for December 10, 2025, and represents a non-competitive set-aside contract. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a contract ceiling value of $1,733.90. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, representing a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,407.70 for the supply of Ondansetron ODT 4 mg tablets (30-count) on December 9, 2025, with ultimate completion by December 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $13,532.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a firm fixed price structure. The award, issued on December 15, 2025, is a non-set-aside, competitively awarded contract with an ultimate completion date of December 16, 2025. This delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.95 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on December 16, 2025, with an ultimate completion date of December 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,595.64 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on December 4, 2025, with completion scheduled for December 5, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract represents a single pharmaceutical procurement supporting federal medical supply needs, leveraging AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, with a ceiling value of $50,714.52. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award utilizes no set-aside designation and represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,595.10 on December 16, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded without set-aside provisions, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $7,553.06 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with an ultimate completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,843.10 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on December 15, 2025, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order was not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCV7ADelivery Order
The Defense Logistics Agency awarded a $58,502.09 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order, which falls under the company's broader federal pharmaceutical supply operations. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains. The DLA leverages this prime vendor contract to efficiently procure critical medications and supplies for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $58.5k | 12/17/25 |